Bio Terra Med S.R.L
- Address
- Calea Grivitei Nr 3 District 1, 010701 Bucharest, Romania
Bio Terra Med S.R.L - Dermatology and Addiction Medicine Research
Bio Terra Med S.R.L is a clinical research center specializing in advanced therapeutic development across dermatology and addiction medicine. The center demonstrates particular expertise in conducting complex Phase 3 trials for chronic conditions requiring long-term management and innovative treatment approaches.
- Moderate to severe plaque psoriasis treatment development and long-term safety evaluation
- Novel biologic therapies including ESK-001 for dermatological conditions
- Alcohol use disorder interventions focusing on reduction of heavy drinking behaviors
The facility has established capabilities in conducting both randomized, double-blind, placebo-controlled trials and extension studies to evaluate durability of treatment response. Bio Terra Med's research portfolio reflects a commitment to addressing significant unmet medical needs in chronic inflammatory skin diseases and substance use disorders, with emphasis on both efficacy outcomes and long-term safety monitoring in patient populations requiring sustained therapeutic interventions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Alumis Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Bio Terra Med S.R.L
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Sunobinop Tosilate on Alcohol Consumption and Craving in Patients with Moderate to Severe Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled Study | Knoa Pharma LLC | Phase II | Not Recruiting | May 2025 | May 2026 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Envudeucitinib | 2 | Unknown | 2025-02-20 | 2025-06-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.